Decision Diagnostics Corp
OTC:DECN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Decision Diagnostics Corp
Capital Expenditures
Decision Diagnostics Corp
Capital Expenditures Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Capital Expenditures | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Decision Diagnostics Corp
OTC:DECN
|
Capital Expenditures
$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Veeva Systems Inc
NYSE:VEEV
|
Capital Expenditures
-$29.1m
|
CAGR 3-Years
-29%
|
CAGR 5-Years
-27%
|
CAGR 10-Years
-3%
|
|
|
Inspire Medical Systems Inc
NYSE:INSP
|
Capital Expenditures
-$38.5m
|
CAGR 3-Years
-62%
|
CAGR 5-Years
-73%
|
CAGR 10-Years
N/A
|
|
|
Doximity Inc
NYSE:DOCS
|
Capital Expenditures
-$6.5m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
N/A
|
|
|
Omnicell Inc
NASDAQ:OMCL
|
Capital Expenditures
-$60.4m
|
CAGR 3-Years
0%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
-12%
|
|
|
W
|
Waystar Holding Corp
NASDAQ:WAY
|
Capital Expenditures
-$26.5m
|
CAGR 3-Years
-15%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Decision Diagnostics Corp
Glance View
Decision Diagnostics Corp. engages in prescription and non-prescription diagnostics and home testing products. The company is headquartered in Westlake Village, California. The company went IPO on 2002-02-08. The firm through its subsidiary, PharmaTech Solutions, Inc.,provides blood glucose home testing test strips. Its blood glucose home testing devices include GenUltimate and PetSure test strips, and GenUltimate 4Pets monitoring system. Its technology includes MD@Hand, which is a wireless, personal digital assistant in the form of a smartphone app that can be downloaded and used by physicians to access and update their patient’s histories, medication data, and care guidelines. The company develops cell phone centric, e-health products and technology. Practice Probe is the data mining utility meant to complement the digital assistant, MD@Hand. Additionally, it offers ResidenceWare, a collection of Internet-enhanced communication, integration, and networking tools developed for the real estate marketplace.
See Also
What is Decision Diagnostics Corp's Capital Expenditures?
Capital Expenditures
0
USD
Based on the financial report for Dec 31, 2020, Decision Diagnostics Corp's Capital Expenditures amounts to 0 USD.
